Targeted cancer drugs may replace chemo for some patients — and drugmakers say they’re getting closer by CNBC Markets | June 17, 2025 5:05 pm | US Markets Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve their efficacy and safety.
